Training Response Artificial Intelligence Network (TRAIN)

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 4 more changesShow less
    • Primary completion moved earlier from Apr 30, 2028 to May 30, 2027
    • Eligibility criteria expanded, about 18 words
    • Study description revised
    • Site details revised
  2. 2 versions Re-verified since Dec 3, 2024, no change to tracked fieldsv8-v9
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2, 2023 to Oct 9, 2023
    • Site details revised
    v7
  4. Start date: Aug 2023 to Oct 2, 2023v6
  5. Eligibility criteria expanded, about 1 word
    • Study description expanded, about 1 word
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Jul 2023 to Aug 2023
    • Interventions: Cognitive Training (Behavioral), Educational training (Behavioral) to Cognitive Training (Behavioral), Computerized Cognitive Stimulation (Behavioral)
    • Study description expanded, about 64 words
    • Collaborators expanded, about 5 words
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Collaborators shortened, about 5 wordsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will train a machine learning tool to predict response to a cognitive training intervention using baseline brain MRI sequences from older adults with amnestic mild cognitive impairment.
Trial Details
NCT Number NCT05903573
Lead Sponsor University of Florida
Collaborators: National Institute on Aging (NIA)
Conditions
(from sponsor)		 Amnestic Mild Cognitive Impairment
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov